AbbVie Inc. is 19.5x more valuable than Roivant Sciences Ltd. by market capitalization ($399.47 B vs $20.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ROIV | ABBV |
|---|---|---|
| Market cap | $20.43 B | $399.47 B |
| US-listed rank | #607 | #28 |
| Revenue (latest FY) | $8.26M | $61.16B |
| Net income (latest FY) | -$299.77M | $4.23B |
| Net margin | -3629.2% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 868 | 1,008 |
AbbVie Inc. is 19.5x more valuable than Roivant Sciences Ltd. by market capitalization ($399.47 B vs $20.43 B).
In their latest fiscal years, Roivant Sciences Ltd. reported $8.26M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Roivant Sciences Ltd. and AbbVie Inc., or browse the full rankings.